Mibe

What Mibe does

Mibe GmbH Arzneimittel is a German pharmaceutical manufacturer and wholly-owned subsidiary of Dermapharm AG, a publicly listed Frankfurt Stock Exchange pharmaceutical conglomerate. Founded in 2003 (originating as Naturapharm GmbH in 2002) and headquartered in Brehna in the Leipzig/Halle metropolitan area, the company operates the largest pharmaceutical production site within the Dermapharm Group, employing over 700 staff.

The company manufactures prescription pharmaceuticals, over-the-counter products, cosmetics, and nutritional supplements across a diversified dosage-form portfolio including tablets, liquids, ointments, sterile dosage forms, hormonal preparations and contraceptives, and eye ointments. Manufacturing capability has been built through a series of phased expansions: sterile dosage forms authorization in 2008, a separate hormone production area in 2010, Salmiak extrusion technology in 2011, eye ointment facilities in 2015, a central shipping warehouse (Building 4) in 2019, and a microbiological laboratory in 2021. The company runs modern chemical-physical and microbiological laboratories and performs approximately 97% of analyses in-house, supporting rapid product release.

Mibe's commercial model is B2B, selling to pharmaceutical wholesalers and pharmacies in Germany, Austria, Croatia, Switzerland, Poland, Italy, Spain, France, and non-European regions. Its Brehna facility functions as the central logistics hub for the entire Dermapharm corporate group, with 27,000 pallet spaces, more than 6,000 commission areas, and reported delivery times of 24 hours to pharmacies and 48 hours to wholesalers. Pricing is not publicly disclosed and revenue figures are not separately reported, with revenue, R&D, and capital allocation decisions made within the Dermapharm AG corporate structure.

Name

Mibe

Legal name

mibe GmbH Arzneimittel

Website

https://mibe.de

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Mibe GmbH Arzneimittel is a German pharmaceutical manufacturer and Dermapharm AG subsidiary that produces prescription drugs, OTC products, cosmetics, and nutritional supplements at its Brehna facility, supplying wholesalers and pharmacies across Europe.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

Keywords

• Pharmaceutical manufacturing
• Generic drug production
• Sterile dosage forms
• Hormone preparations manufacturing
• Contract manufacturing services

Headquarters

HQ city

Brehna

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Infrastructure, Technology or R&D

Revenue model

1. Pharmaceutical Product Sales: Manufactures and sells prescription and non-prescription pharmaceutical products, cosmetics, and nutritional supplements to wholesalers and pharmacies across Europe

Go-to-market motion1 record

Distribution channels3 records

Marketing channels2 records

Core offering

mibe GmbH Arzneimittel manufactures pharmaceutical products including prescription medicines, over-the-counter medications, cosmetics, and nutritional supplements at its GMP-certified facility in Brehna, Germany. With over 700 employees, the company produces tablets, liquids, ointments, sterile dosage forms, hormone preparations, and eye ointments for distribution to wholesalers and pharmacies across Germany, Austria, and other European markets. As the largest production site within the Dermapharm Group, it also operates the central shipping and logistics hub for the entire corporate group.

Product overview

Mibe GmbH Arzneimittel is a pharmaceutical manufacturing company and subsidiary of Dermapharm AG, operating as the largest pharmaceutical production site within the group. The company produces prescription products (rezeptpflichtige Produkte), over-the-counter products (rezeptfreie Produkte), cosmetics (Kosmetika), and nutritional supplements (Nahrungsergänzungsmittel) at its state-of-the-art facility in Sandersdorf-Brehna, Germany. With over 700 employees, the company manufactures tablets, liquids, ointments, sterile dosage forms, hormone preparations, and eye ointments. The company conducts 97% of analyses in-house through its modern laboratories and distributes products across Germany, Austria, and other European markets. The product portfolio follows a traditional pharmaceutical manufacturer model with prescription and non-prescription divisions serving pharmacies, wholesalers, and healthcare providers.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• 97% of analyses performed in-house for rapid product release
• +2 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Ten partnerships are on record, tiered core and minor.

• Dermapharm AGcoreStrategic or Co-development PartnerParent company. Mibe GmbH Arzneimittel is a wholly-owned subsidiary of Dermapharm AG and serves as the largest pharmaceutical production site within the group. Central logistics hub ships products for the entire Dermapharm corporate group.
• acisminorOthersSister company within Dermapharm Group
• AllergopharmaminorOthersSister company within Dermapharm Group specializing in allergy treatments
• ArkopharmaminorOthersSister company within Dermapharm Group (French subsidiary)
• axicorp pharmaminorOthersSister company within Dermapharm Group
• candoro ethicsminorOthersSister company within Dermapharm Group
• huebner vitalminorOthersSister company within Dermapharm Group specializing in health products
• mibetecminorOthersSister company within Dermapharm Group
• StrathmannminorOthersSister company within Dermapharm Group
• TrommsdorffminorOthersSister company within Dermapharm Group

Scale indicators4 records

Recent moves17 records

Expansion highlights4 records

Direct peers

• Aenova Group: German-headquartered pharmaceutical contract manufacturer offering solid dosage forms, sterile liquids, and semi-solids from multiple European sites. Directly comparable to Mibe as a European CDMO serving generics and branded pharma customers with similar dosage-form breadth.
• Fareva: French-headquartered global pharmaceutical CDMO with extensive European manufacturing footprint across multiple dosage forms. Comparable to Mibe as a pan-European contract manufacturer serving branded and generic pharma customers.
• Penta Arzneimittel: German pharmaceutical company producing solid and liquid dosage forms including sterile products at a single German site. Comparable to Mibe in dosage-form capabilities, single-site German manufacturing, and generic/OTC portfolio.
• bene-Arzneimittel: German generic and specialty pharmaceutical manufacturer producing tablets, liquids, and semi-solids from a single German site. Comparable to Mibe in product mix, German manufacturing focus, and generic-pharma distribution model.
• Hevert-Arzneimittel: German manufacturer of pharmaceuticals, homeopathic, and plant-based medicinal products, with German-based production. Comparable to Mibe in German manufacturing base and mix of allopathic plus natural/botanical products.
• Hermes Arzneimittel: German pharmaceutical manufacturer with own branded OTC and generics portfolio, producing in-house at German facilities. Comparable to Mibe in vertical integration, German production, and B2B/wholesale distribution channels.
• Merkle GmbH: German CDMO specializing in solid and semi-solid pharmaceutical production, including effervescent tablets and sterile liquids. Closely comparable to Mibe's dosage-form portfolio and European contract-manufacturing positioning.

Broad incumbents

• Corden Pharma: European-based CDMO with strong sterile injectables, hormones, and API manufacturing capabilities across multiple sites. Comparable to Mibe particularly in the hormone/sterile specialty space where Mibe operates its dedicated Brehna facilities.
• Stada Arzneimittel AG: Large German-headquartered generic and specialty pharma company with substantial European manufacturing footprint. Comparable to Mibe as a generic-pharma competitor serving the same German pharmacy/wholesaler channels, though at significantly greater scale and with broader branded portfolio.
• Cheplapharm Arzneimittel: German specialty pharmaceutical company that acquires and manages established branded pharmaceutical products with European-wide distribution. Comparable to Mibe/Dermapharm as a German pharma player distributing prescription and OTC products through European wholesalers and pharmacies.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mibe